Yeah I'll have a go without going back to the recording. I think, according to my aging synapses that the question was aimed on the potential for other autoimmune diseases e.g. psoriatic athritis, and SI loved the question and replied about the real promise for applicability to to other disease states and how MSB's treatment for RA is really their most important application because of this potential. All very exciting. I just hope MSB doesn't fall at a hurdle with trying to be too tricky with their statistical analyses and use of measuring devices in their trials in a desparate attempt to attain the statistical significance so essential to prove the technology is not just safe "Disallowed". So far the jury is in on safety but out on efficacy. Not long now for the all important CHF interim stats which should begin to clear the debate up one way or the other.
- Forums
- ASX - By Stock
- MSB
- Heart Failure
Heart Failure, page-56
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 5440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | 1.460 |
2 | 19558 | 1.455 |
5 | 49977 | 1.450 |
5 | 102249 | 1.445 |
2 | 30389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 5440 | 3 |
1.470 | 22187 | 2 |
1.475 | 84389 | 3 |
1.480 | 118230 | 9 |
1.485 | 96793 | 8 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online